Catalyst Wire Dossier Catalyst Wire Dossier

R-Flurbiprofen

R-flurbiprofen (R-enantiomer of flurbiprofen) · Myrexis Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for R-Flurbiprofen, covering 2013-12-18 to 2015-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects [Phase 1]

See pricing